Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Dec 24, 2025The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS INC | A | A | $52.67B | $3.21B | $151.92M | $43.57M | $0.31 | 53.24% | 51.59% | N/A | N/A | 2026-02-12 |
| ONC | BEONE MEDICINES LTD | A | A | $34.60B | $4.97B | $318.03M | $68.55M | $0.05 | 49.92% | 79.66% | N/A | N/A | |
| FIX | COMFORT SYSTEMS USA INC | A | A | $34.05B | $8.32B | $1.21B | $837.62M | $23.67 | 27.71% | 23.67% | 80.55% | 43.80% | |
| NVT | NVENT ELECTRIC PLC | A | A | $16.78B | $3.58B | $1.08B | $602.10M | $3.67 | 21.54% | 11.85% | 5.76% | N/A | 2026-02-05 |
| NBIX | NEUROCRINE BIOSCIENCES INC | A | B | $14.68B | $2.68B | $679.20M | $428.00M | $4.31 | 19.61% | 20.82% | 11.66% | 33.67% | 2026-02-11 |
| VTRS | VIATRIS INC | A | B | $13.84B | $14.12B | -$598.90M | -$3.69B | -$3.09 | -6.14% | 4.17% | N/A | N/A | |
| JAZZ | JAZZ PHARMACEUTICALS PLC | A | B | $10.30B | $4.16B | $182.64M | -$368.48M | -$5.99 | 4.14% | 12.77% | N/A | N/A | |
| SGHC | SUPER GROUP (SGHC) LTD | A | C | $6.05B | $2.50B | N/A | $250.52M | $0.50 | 37.25% | N/A | 2,420.00% | N/A | |
| GTES | GATES INDUSTRIAL CORP PLC | A | B | $5.73B | $3.42B | $672.10M | $236.70M | $0.92 | -0.75% | 4.63% | 9.52% | 29.77% | |
| CPA | COPA HOLDINGS SA | A | C | $5.02B | $3.45B | $1.12B | $608.11M | $14.55 | -0.31% | 4.94% | 13.85% | 20.15% | 2026-02-18 |
| UGP | ULTRAPAR HOLDINGS INC | A | B | $4.03B | $22.98B | $1.18B | $406.67M | $0.37 | -16.54% | 0.81% | -24.07% | 32.18% | |
| CALX | CALIX INC | A | A | $3.67B | $933.69M | $10.21M | -$7.25M | -$0.10 | 4.89% | 13.70% | N/A | N/A | 2026-01-26 |
| SPNT | SIRIUSPOINT LTD | A | A | $2.62B | $2.84B | $339.10M | $182.30M | $1.66 | 7.87% | 30.11% | 0.00% | 32.93% | 2026-02-19 |
| HCI | HCI GROUP INC | A | A | $2.54B | $816.58M | $301.16M | $203.94M | $17.26 | 8.75% | 21.90% | 16.23% | 33.77% | |
| EXTR | EXTREME NETWORKS INC | A | A | $2.24B | $1.18B | $65.83M | $8.65M | $0.07 | 14.31% | 4.93% | N/A | N/A | 2026-02-04 |
| ANIP | ANI PHARMACEUTICALS INC | A | A | $1.81B | $826.88M | $165.21M | $39.01M | $1.71 | 48.87% | 32.93% | N/A | N/A | |
| BLBD | BLUE BIRD CORP | A | C | $1.65B | $1.48B | $194.43M | $127.72M | $4.01 | 9.87% | 10.98% | 22.63% | 54.88% | 2026-02-11 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | A | A | $1.59B | $599.82M | $83.87M | -$8.78M | -$0.05 | 45.38% | 62.14% | N/A | N/A | |
| DNOW | DNOW INC | A | C | $1.43B | $2.43B | $165.00M | $95.00M | $0.89 | 3.18% | 4.64% | -52.66% | N/A | 2026-02-12 |
| ANAB | ANAPTYSBIO INC | A | B | $1.39B | $169.47M | -$82.14M | -$84.63M | -$2.74 | 196.42% | 56.59% | N/A | N/A | |
| DFIN | DONNELLEY FINANCIAL SOLUTIONS INC | A | C | $1.23B | $750.80M | $119.00M | $32.50M | $1.11 | -6.40% | -3.00% | -66.47% | 17.77% | 2026-02-24 |
| TBLA | TABOOLACOM LTD | A | B | $1.20B | $1.88B | $137.29M | $25.29M | $0.08 | 10.96% | N/A | N/A | N/A | 2026-02-19 |
| NUTX | NUTEX HEALTH INC | A | C | $1.18B | $981.20M | $227.40M | $120.57M | $21.20 | 236.03% | N/A | N/A | N/A | |
| CRTO | CRITEO SA | A | C | $1.07B | $1.96B | $219.28M | $168.06M | $3.12 | 0.53% | -1.06% | 71.43% | 23.41% | 2026-02-11 |
| TBPH | THERAVANCE BIOPHARMA INC | A | C | $940.99M | $80.33M | $55.37M | $29.34M | $0.58 | 27.12% | -0.56% | N/A | N/A | |
| ORGO | ORGANOGENESIS HOLDINGS INC | A | A | $729.74M | $465.22M | $18.04M | -$13.39M | -$0.12 | 2.24% | 8.73% | N/A | N/A | |
| BWMX | BETTERWARE DE MEXICO SAPI DE CV | A | B | $515.71M | $770.18M | $145.14M | $55.54M | N/A | 11.00% | 26.08% | N/A | N/A | |
| VREX | VAREX IMAGING CORP | A | A | $502.90M | $844.60M | -$1.00M | -$70.30M | -$1.70 | 4.14% | 2.73% | N/A | N/A | |
| LE | LANDS' END INC | A | B | $434.44M | $1.31B | $86.84M | $11.75M | $0.37 | -8.47% | -1.79% | N/A | -5.84% | |
| EGHT | 8X8 INC | A | B | $273.12M | $721.38M | $51.06M | -$5.93M | -$0.04 | 0.25% | 8.00% | N/A | N/A | 2026-02-04 |
| OPRX | OPTIMIZERX CORP | A | A | $237.48M | $109.51M | $11.65M | $34.00k | $0.00 | 24.18% | 26.16% | N/A | N/A | |
| ELMD | ELECTROMED INC | A | C | $228.11M | $66.22M | $12.05M | $8.20M | $0.97 | 16.05% | 15.53% | 29.33% | 17.13% | 2026-02-17 |
| LTRX | LANTRONIX INC | A | B | $226.31M | $118.29M | -$5.00M | -$10.27M | -$0.26 | -26.85% | 12.97% | N/A | N/A | |
| CXDO | CREXENDO INC | A | B | $202.82M | $66.35M | $7.94M | $4.36M | $0.15 | 12.91% | 33.25% | 150.00% | 16.47% | |
| INFU | INFUSYSTEM HOLDINGS INC | A | C | $183.84M | $141.05M | $24.16M | $5.52M | $0.26 | 6.23% | 8.37% | 333.33% | -7.31% |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.